Fifty years ago, Ashbaugh and colleagues described 12 patients with tachypnea, refractory hypoxemia, and diffuse opacities on chest radiographs after infection or trauma. 1 Prominent hyaline membranes ...
Acute respiratory distress syndrome (ARDS) has been associated with considerable morbidity and mortality, even before the COVID-19 pandemic hit. For the most part, ARDS management is limited to ...
Acute respiratory distress syndrome (ARDS) is characterized by increased pulmonary inflammation and endothelial barrier permeability. Omentin has been shown to benefit obesity-related systemic ...
Breathing troubles can feel frightening, especially when the cause is serious. Among the many lung conditions, two names that often come up are pneumonia and Acute Respiratory Distress Syndrome (ARDS) ...
New study of 645 ARDS survivors has identified subgroups of ARDS survivors who suffer what's been called post-intensive care syndrome, a collection of symptoms that can linger for years. Patients who ...
An initial trial suggests that a new drug, originally developed for use with cancer patients, could improve the survival of patients with acute respiratory distress syndrome (ARDS). The patients in ...
The SARS-CoV-2 pandemic has inspired new interest in understanding the fundamental pathology of acute respiratory distress syndrome (ARDS), which has been associated with severe coronavirus disease ...
Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension plus acute respiratory distress syndrome resulted in poor hospital outcomes. Odds for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback